Effect of polymorphisms in the 3′-untranslated region (3′-UTR) of VEGF gene on gastric pre-malignant condition

Anticancer Research

Volumn 29, Issue 2, 2009, Pages 485-489

  Tahara, Tomomitsu ^a   Arisawa, Omiyasu ^c   Shibata, Tomoyuki ^a   Nakamura, Masakatsu ^a   Yamashita, Hiromi ^a   Yoshioka, Daisuke ^a   Okubo, Masaaki ^a   Maruyama, Naoko ^a   Kamano, Toshiaki ^a   Kamiya, Yoshio ^a   Fujita, Hiroshi ^a   Nagasaka, Mitsuo ^a   Iwata, Masami ^a   Takahama, Kazuya ^a   Watanabe, Akoto ^a   Nakano, Hiroshi ^b   Hirata, Ichiro ^a  

^a Department of Gastroenterology ^*  (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Helicobacter pylori; Intestinal metaplasia; Polymorphism; VEGF

Indexed keywords

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RISK; FEMALE; GASTRITIS; GENE; GENETIC POLYMORPHISM; GENOTYPE; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INCIDENCE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PRECANCER; PRIORITY JOURNAL; STOMACH ANTRUM; STOMACH CANCER; VEGF GENE;

3' UNTRANSLATED REGIONS; AGED; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECANCEROUS CONDITIONS; STOMACH NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 61449180447     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 272: 65-69, 1994.
2. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N and Schlemper RJ: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345: 784-789, 2001.
3. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N and Sibley RK: Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325: 1127-1131, 1991.
4. Huang JQ, Sridhar S, Chen Y and Hunt RH: Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 114: 1169-1179, 1998.
5. Blaser MJ and Parsonnet J: Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 94: 4-8, 1994.
6. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ and Holash J: Vascular-specific growth factors and blood vessel formation. Nature 407: 242-248, 1994:
7. Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature 407: 249-257, 2000.
8. Dvorak HF, Brown LF, Detmar M and Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146: 1029-1039, 1995.
9. Jones MK, Wang H, Peskar BM, Levin E, Itani RM, Sarfeh IJ and Tarnawski AS: Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 5: 1418-1423, 1999.
10. Jones MK, Kawanaka H, Baatar D, Szabo IL, Tsugawa K, Pai R, Koh GY, Kim I, Sarfeh IJ and Tarnawski AS: Gene therapy for gastric ulcers with single local injection of naked DNA encoding VEGF and angiopoietin-1. Gastroenterology 121: 1040-1047, 2001.
11. Suzuki N, Takahashi S and Okabe S: Relationship between vascular endothelial growth factor and angiogenesis in spontaneous and indomethacin-delayed healing of aceticacid-induced gastric ulcers in rats. J Physiol Pharmacol 49: 515-527, 1998.
12. Takahashi Y, Cleary KR, Mai M, Kitadai Y, Bucana CD and Ellis LM: Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Clin Cancer Res 2: 1679-1684, 1996.
13. Maeda K, Kang SM, Onoda N, Ogawa M, Kato, Y, Sawada, T and Chung KH: Vascular endothelial growth factor expression in preoperative biopsy specimens correlates with disease recurrence in patients with early gastric carcinoma. Cancer 86: 566-571, 1999.
14. Feng CW, Wang LD, Jiao LH, Liu B, Zheng S and Xie XJ: Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features. BMC Cancer 29: 2-8, 2000.
15. Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B and Pilger E: A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vase Res 37: 443-448, 2000.
16. Abe A, Sato K, Habuchi T, Wang L, Li Z, Tsuchiya N, Ohyama C, Satoh S, Ogawa O and Kato T: Single nucleotide polymorphisms in the 3′ untranslated region of vascular endothelial growth factor gene in Japanese population with or without renal cell carcinoma. Tohoku J Exp Med 198: 181-190, 2002.
17. Awata T, Inoue K, Kurihara S, Ohkubo T, Watanabe M, Inukai K, Inoue I and Katayama S: A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 51: 1635-1639, 2002.
18. Dixon MF, Genta RM, Yardley JH and Correa P: Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20: 1161-1181, 1996.
19. Morohashi K, Takada T, Omori K, Suzuki E and Gejyo F: Vascular endothelial growth factor gene polymorphisms in Japanese patients with sarcoidosis. Chest 123: 1520-1526, 2003.
20. Caputo R, Tuccillo C, Manzo BA, Zarrilli R, Tortora G, Blanco Cdel V, Ricci V, Ciardiello F and Romano M: Helicobacter pylori VacA toxin up-regulates vascular endothelial growth factor expression in MKN 28 gastric cells through an epidermal growth factor receptor-, cyclooxygenase-2-dependent mechanism. Clin Cancer Res 9: 2015-2021, 2003.
21. Kitadai Y, Sasaki A, Ito M, Tanaka S, Oue N, Yasui W, Aihara M, Imagawa K, Haruma K and Chayama K: Helicobacter pylori infection influences expression of genes related to angiogenesis and invasion in human gastric carcinoma cells. Biochem Biophys Res Common 311: 809-814, 2003.
22. Dibbens JA, Miller DL, Damert A, Risau W, Vadas MA and Goodall CJ: Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements. Mol Biol Cell 10: 907-919, 1999.
23. Greener MJ, Sewry CA, Muntoni F and Roberts RG: The 3′-untranslated region of the dystrophin gene - conservation and consequences of loss. Eur J Hum Genet 10: 413-420, 2002.
24. Iida K, Kawakami Y, Sone H, Suzuki H, Yatoh S, Isobe K, Takekoshi K and Yamada N: Vascular endothelial growth factor gene expression in a retinal pigmented cell is up-regulated by glucose deprivation through 3' UTR. Life Sci 71: 1607-1614, 2002.
25. Ma WJ, Cheng S, Campbell C, Wright A, Furneaux H: Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J Biol Chem 271: 8144-8151, 1996.
26. Nabors LB, Gillespie GY, Harkins L and King PH: HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3' untranslated regions of cytokine and angiogenic factor mRNAs. Cancer Res 61: 2154-2161, 2001.
27. Goldberg-Cohen I, Furneauxb H and Levy AP: A 40-bp RNA element that mediates stabilization of vascular endothelial growth factor mRNA by HuR. J Biol Chem 277: 13635-13640, 2002.
28. Ramamoorti N, Kumarvelu J, Shanmugasundaram GK, Rani K and Banerjea AC: High frequency of G to A transition mutation in the stromal cell derived factor-1 gene in India, a chemokine that blocks HIV-1 (X4) infection: multiple proteins bind to 3′-untranslated region of SDF-1 RNA. Genes Immun 2: 408-410, 2001.
29. Tzanakis N, Gazouli M, Rallis G, Giannopoulos G, Papaconstantinou I, Theodoropoulos G, Pikoulis E, Tsigris C, Karakitsos P, Peros G and Nikiteas N: Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival. J Surg Oncol 94: 624-630, 2006.
30. Chae YS, Kim JG, Sohn SK, Cho YY, Moon JH, Bae HI, Park JY, Lee MH, Lee HC, Chung HY and Yu W: Investigation of vascular endothelial growth factor gene polymorphisms and its association with clinicopathologic characteristics in gastric cancer. Oncology 71: 266-272, 2006.
31. Kim JG, Sohn SK, Chae YS, Cho YY, Bae HI, Yan G, Park JY, Lee MH, Chung HY and Yu W: Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with gastric cancer. Ann Oncol 18: 1030-1036, 2007.